Top

International Journal of Clinical Oncology

Published in:

01-04-2020 | Original Article

Associations between expression levels of nine core nucleotide excision repair genes in lymphocytes and risk of head and neck squamous cell carcinomas in a Chinese population

Authors: Pengyu Ren, Xiaorong Niu, Chang Liu, Junsong Liu, Honghui Li, Qian Zhao, Juanli Xing, Yanxia Bai, Yiqian Liang, Peng Han

Published in: International Journal of Clinical Oncology | Issue 4/2020

Abstract

Background

Head and neck squamous cell carcinomas (HNSCCs) are one of the most common cancers in the world, and nucleotide excision repair (NER) is involved in HNSCCs susceptibility. We investigated whether mRNA expression levels of nine core NER genes were associated with risk of HNSCCs in a Chinese population.

Methods

In this study of 251 HNSCC patients and 232 healthy controls, we quantified NER gene mRNA expression levels in cultured peripheral lymphocytes using a quantitative real-time PCR.

Results

Compared with the controls, HNSCC patients had statistically significantly lower expression levels of XPA and XPB (P = 0.029 and 0.001, respectively). After dividing the subjects by the controls’ median values of expression levels, we found a dose-dependent association between an increased risk of HNSCCs and low expression levels of XPB (adjusted OR 1.56 and 95% CI 1.07–2.28; P_trend = 0.001). We also identified a significant multiplicative interaction between smoking status as well as alcohol status and mRNA expression levels of XPB (P = 0.014 and 0.042, respectively). Finally, after integrating demographic variables, we found the addition of smoking status and XPB expression levels to the model significantly improved the sensitivity of the expanded model on HNSCC risk.

Conclusion

Reduced mRNA expression levels of XPB were associated with an increased risk of HNSCCs in a Chinese population.

Available only for authorised users

Wissinger E, Griebsch I, Lungershausen J et al (2014) The humanistic burden of head and neck cancer: a systematic literature review. Pharmaco Econ 32(12):1213–1229. https://doi.org/10.1007/s40273-014-0199-x CrossRef

Ferlay J, Soerjomataram I, Dikshit R et al (2015) Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136(5):E359–386. https://doi.org/10.1002/ijc.29210 CrossRefPubMed

Jou A, Hess J (2017) Epidemiology and Molecular Biology of Head and Neck Cancer. Oncol Res Treat 40(6):328–332. https://doi.org/10.1159/000477127 CrossRefPubMed

Jemal A, Siegel R, Ward E et al (2009) Cancer statistics, 2009. CA 59(4):225–249. https://doi.org/10.3322/caac.20006 CrossRefPubMed

Siegel RL, Miller KD, Jemal A (2019) Cancer statistics, 2019. CA 69(1):7–34. https://doi.org/10.3322/caac.21551 CrossRefPubMed

Mourad M, Jetmore T, Jategaonkar AA et al (2017) Epidemiological trends of head and neck cancer in the United States: a SEER population study. J Oral Maxillofac Surg 75(12):2562–2572. https://doi.org/10.1016/j.joms.2017.05.008 CrossRefPubMedPubMedCentral

Chen W, Zheng R, Baade PD et al (2016) Cancer statistics in China, 2015. CA 66(2):115–132. https://doi.org/10.3322/caac.21338 CrossRefPubMed

Ang KK, Harris J, Wheeler R et al (2010) Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med 363(1):24–35. https://doi.org/10.1056/NEJMoa0912217 CrossRefPubMedPubMedCentral

Hashibe M, Brennan P, Chuang SC et al (2009) Interaction between tobacco and alcohol use and the risk of head and neck cancer: pooled analysis in the international head and neck cancer epidemiology consortium. Cancer Epidemiol Biomark Prev 18(2):541–550. https://doi.org/10.1158/1055-9965.EPI-08-0347 CrossRef

10.

Ducatman BS (2018) The role of human papillomavirus in oropharyngeal squamous cell carcinoma. Arch Pathol Lab Med 142(6):715–718. https://doi.org/10.5858/arpa.2018-0083-RA CrossRefPubMed

11.

Kawakita D, Matsuo K (2017) Alcohol and head and neck cancer. Cancer Metastasis Rev 36(3):425–434. https://doi.org/10.1007/s10555-017-9690-0 CrossRefPubMed

12.

Dylawerska A, Barczak W, Wegner A et al (2017) Association of DNA repair genes polymorphisms and mutations with increased risk of head and neck cancer: a review. Med Oncol 34(12):197. https://doi.org/10.1007/s12032-017-1057-4 CrossRefPubMedPubMedCentral

13.

Li D, Wang LE, Chang P et al (2007) In vitro benzo[a]pyrene diol epoxide-induced DNA adducts and risk of squamous cell carcinoma of head and neck. Can Res 67(12):5628–5634. https://doi.org/10.1158/0008-5472.CAN-07-0983 CrossRef

14.

Xiong P, Hu Z, Li C et al (2007) In vitro benzo[a]pyrene diol epoxide-induced DNA damage and chromosomal aberrations in primary lymphocytes, smoking, and risk of squamous cell carcinoma of the head and neck. Int J Cancer 121(12):2735–2740. https://doi.org/10.1002/ijc.23054 CrossRefPubMed

15.

Sancar A (2016) Mechanisms of DNA repair by photolyase and excision nuclease (Nobel Lecture). Angew Chem 55(30):8502–8527. https://doi.org/10.1002/anie.201601524 CrossRef

16.

Turgeon MO, Perry NJS, Poulogiannis G (2018) DNA damage, repair, and cancer metabolism. Frontiers Oncol 8:15. https://doi.org/10.3389/fonc.2018.00015 CrossRef

17.

Spivak G (2015) Nucleotide excision repair in humans. DNA Repair 36:13–18. https://doi.org/10.1016/j.dnarep.2015.09.003 CrossRefPubMedPubMedCentral

18.

Liu Z, Liu H, Gao F et al (2016) Reduced DNA double-strand break repair capacity and risk of squamous cell carcinoma of the head and neck—a case-control study. DNA Repair 40:18–26. https://doi.org/10.1016/j.dnarep.2016.02.003 CrossRefPubMedPubMedCentral

19.

Weaver AN, Cooper TS, Rodriguez M et al (2015) DNA double strand break repair defect and sensitivity to poly ADP-ribose polymerase (PARP) inhibition in human papillomavirus 16-positive head and neck squamous cell carcinoma. Oncotarget 6(29):26995–27007. https://doi.org/10.18632/oncotarget.4863 CrossRefPubMedPubMedCentral

20.

Sancar A, Boltz LA, Unsal-Kacmaz K et al (2004) Molecular mechanisms of mammalian DNA repair and the DNA damage checkpoints. Annu Rev Biochem 73:39–85. https://doi.org/10.1146/annurev.biochem.73.011303.073723 CrossRefPubMed

21.

Li C, Wang LE, Wei Q (2009) DNA repair phenotype and cancer susceptibility—a mini review. Int J Cancer 124(5):999–1007. https://doi.org/10.1002/ijc.24126 CrossRefPubMedPubMedCentral

22.

Cleaver JE, Lam ET, Revet I (2009) Disorders of nucleotide excision repair: the genetic and molecular basis of heterogeneity. Nat Rev Genet 10(11):756–768. https://doi.org/10.1038/nrg2663 CrossRefPubMed

23.

Cleaver JE (2000) Common pathways for ultraviolet skin carcinogenesis in the repair and replication defective groups of xeroderma pigmentosum. J Dermatol Sci 23(1):1–11CrossRef

24.

Cleaver JE (2005) Cancer in xeroderma pigmentosum and related disorders of DNA repair. Nat Rev Cancer 5(7):564–573. https://doi.org/10.1038/nrc1652 CrossRefPubMed

25.

Hijazi H, Salih MA, Hamad MH et al (2015) Pellagra-like condition is xeroderma pigmentosum/Cockayne syndrome complex and niacin confers clinical benefit. Clin Genet 87(1):56–61. https://doi.org/10.1111/cge.12325 CrossRefPubMed

26.

Wang LE, Hu Z, Sturgis EM et al (2010) Reduced DNA repair capacity for removing tobacco carcinogen-induced DNA adducts contributes to risk of head and neck cancer but not tumor characteristics. Clin Cancer Res 16(2):764–774. https://doi.org/10.1158/1078-0432.CCR-09-2156 CrossRefPubMedPubMedCentral

27.

Cheng L, Eicher SA, Guo Z et al (1998) Reduced DNA repair capacity in head and neck cancer patients. Cancer Epidemiol Biomark Prev 7(6):465–468

28.

Han P, Gao F, Liu H et al (2017) Reduced mRNA expression of nucleotide excision repair genes in lymphocytes and risk of squamous cell carcinoma of the head and neck. Carcinogenesis 38(5):504–510. https://doi.org/10.1093/carcin/bgx028 CrossRefPubMedPubMedCentral

29.

Zhang YX, Zhang B, Gao L et al (2013) Clinical analysis of 318 cases of oropharyngeal squamous cell carcinoma. Zhonghua er bi yan hou tou jing wai ke za zhi Chinese Journal of Otorhinolaryngology Head and Neck Surgery 48(5):398–404PubMed

30.

Huang H, Zhang B, Chen W et al (2012) Human papillomavirus infection in oropharyngeal squamous cell carcinoma and prognosis: a preliminary analysis of 66 cases. Zhonghua er bi yan hou tou jing wai ke za zhi Chinese Journal of Otorhinolaryngology Head and Neck Surgery 47(3):207–211PubMed

31.

Shah A, Malik A, Garg A et al (2017) Oral sex and human papilloma virus-related head and neck squamous cell cancer: a review of the literature. Postgrad Med J 93(1105):704–709. https://doi.org/10.1136/postgradmedj-2016-134603 CrossRefPubMed

32.

Castellsague X, Alemany L, Quer M et al (2016) HPV Involvement in head and neck cancers: comprehensive assessment of biomarkers in 3680 patients. J Natl Cancer Inst 108(6):djv403. https://doi.org/10.1093/jnci/djv403 CrossRef

33.

Leemans CR, Snijders PJF, Brakenhoff RH (2018) The molecular landscape of head and neck cancer. Nat Rev Cancer 18(5):269–282. https://doi.org/10.1038/nrc.2018.11 CrossRefPubMed

34.

Han P, Liu H, Shi Q et al (2018) Associations between expression levels of nucleotide excision repair proteins in lymphoblastoid cells and risk of squamous cell carcinoma of the head and neck. Mol Carcinog 57(6):784–793. https://doi.org/10.1002/mc.22801 CrossRefPubMedPubMedCentral

35.

Cheng L, Spitz MR, Hong WK et al (2000) Reduced expression levels of nucleotide excision repair genes in lung cancer: a case-control analysis. Carcinogenesis 21(8):1527–1530CrossRef

36.

Hu Z, Xu L, Shao M et al (2006) Polymorphisms in the two helicases ERCC2/XPD and ERCC3/XPB of the transcription factor IIH complex and risk of lung cancer: a case-control analysis in a Chinese population. Cancer Epidemiol Biomark Prev 15(7):1336–1340. https://doi.org/10.1158/1055-9965.EPI-06-0194 CrossRef

37.

Oh KS, Khan SG, Jaspers NG et al (2006) Phenotypic heterogeneity in the XPB DNA helicase gene (ERCC3): xeroderma pigmentosum without and with Cockayne syndrome. Hum Mutat 27(11):1092–1103. https://doi.org/10.1002/humu.20392 CrossRefPubMed

38.

Wang M, Chu H, Zhang Z et al (2013) Molecular epidemiology of DNA repair gene polymorphisms and head and neck cancer. J Biomed Res 27(3):179–192. https://doi.org/10.7555/JBR.27.20130034 CrossRefPubMedPubMedCentral

39.

Cheng L, Sturgis EM, Eicher SA et al (2002) Expression of nucleotide excision repair genes and the risk for squamous cell carcinoma of the head and neck. Cancer 94(2):393–397. https://doi.org/10.1002/cncr.10231 CrossRefPubMed

Title: Associations between expression levels of nine core nucleotide excision repair genes in lymphocytes and risk of head and neck squamous cell carcinomas in a Chinese population
Authors: Pengyu Ren
Xiaorong Niu
Chang Liu
Junsong Liu
Honghui Li
Qian Zhao
Juanli Xing
Yanxia Bai
Yiqian Liang
Peng Han
Publication date: 01-04-2020
Publisher: Springer Singapore
Published in: International Journal of Clinical Oncology / Issue 4/2020
Print ISSN: 1341-9625
Electronic ISSN: 1437-7772
DOI: https://doi.org/10.1007/s10147-019-01586-9

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Background

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 4/2020

Low incidence of late recurrence in patients with intermediate-risk prostate cancer treated by intensity-modulated radiation therapy plus short-term androgen deprivation therapy

Preoperative lymphocyte-to-monocyte ratio predicts postoperative infectious complications after laparoscopic colorectal cancer surgery

The prognostic value of routine second transurethral resection in patients with newly diagnosed stage pT1 non-muscle-invasive bladder cancer: results from randomized 10-year extension trial

Current status and future prospective of focal therapy for localized prostate cancer: development of multiparametric MRI, MRI-TRUS fusion image-guided biopsy, and treatment modalities

A randomized, double-blind, comparison of radium-223 and placebo, in combination with abiraterone acetate and prednisolone, in castration-resistant metastatic prostate cancer: subgroup analysis of Japanese patients in the ERA 223 study

Treatment intensity and control rates in combining external-beam radiotherapy and radioactive iodine therapy for metastatic or recurrent differentiated thyroid cancer

Keynote webinar | Spotlight on antibody–drug conjugates in cancer